Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ChemMedChem
2009 Jan 01;41:110-7. doi: 10.1002/cmdc.200800226.
Show Gene links
Show Anatomy links
Stereocontrolled synthesis and pharmacological evaluation of azetidine-2,3-dicarboxylic acids at NMDA receptors.
Sivaprakasam M
,
Hansen KB
,
David O
,
Nielsen B
,
Traynelis SF
,
Clausen RP
,
Couty F
,
Bunch L
.
???displayArticle.abstract???
The four stereoisomers of azetidine-2,3-dicaroxylic acid (L-trans-ADC, L-cis-ADC, D-trans-ADC, and D-cis-ADC) were synthesized in a stereocontrolled fashion following two distinct strategies: one providing the two cis-ADC enantiomers and one giving access to the two trans-ADC enantiomers. The four azetidinic amino acids were characterized in a radioligand binding assay ([(3)H]CGP39653) at native NMDA receptors: L-trans-ADC showed the highest affinity (K(i)=10 microM) followed by the D-cis-ADC stereoisomer (21 microM). In contrast, the two analogues L-cis-ADC and D-trans-ADC were low-affinity ligands (>100 and 90 microM, respectively). Electrophysiological characterization of the ADC compounds at the four NMDA receptor subtypes NR1/NR2A, NR1/NR2B, NR1/NR2C, and NR1/NR2D expressed in Xenopus oocytes showed that L-trans-ADC displayed the highest agonist potency at NR1/NR2D (EC(50)=50 microM), which was 9.4-, 3.4-, and 1.9-fold higher than the respective potencies at NR1/NR2A-C. D-cis-ADC was shown to be a partial agonist at NR1/NR2C and NR1/NR2D with medium-range micromolar potencies (EC(50)=720 and 230 microM, respectively). A subsequent in silico ligand-protein docking study suggested an unusual binding mode for these amino acids in the agonist binding site.
Arakawa,
Stereospecific synthesis of azetidine-cis-2,3-dicarboxylic acid.
2003, Pubmed
Arakawa,
Stereospecific synthesis of azetidine-cis-2,3-dicarboxylic acid.
2003,
Pubmed
Berg,
(R)-(+)-2-[[[3-(Morpholinomethyl)-2H-chromen-8-yl]oxy]methyl] morpholine methanesulfonate: a new selective rat 5-hydroxytryptamine1B receptor antagonist.
1998,
Pubmed
Bräuner-Osborne,
Ligands for glutamate receptors: design and therapeutic prospects.
2000,
Pubmed
Bräuner-Osborne,
Azetidinic amino acids: stereocontrolled synthesis and pharmacological characterization as ligands for glutamate receptors and transporters.
2005,
Pubmed
Bunch,
Synthesis and receptor binding affinity of new selective GluR5 ligands.
2001,
Pubmed
Clausen,
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligands.
2008,
Pubmed
,
Xenbase
Clausen,
The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
2004,
Pubmed
Cull-Candy,
Role of distinct NMDA receptor subtypes at central synapses.
2004,
Pubmed
Danysz,
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.
1998,
Pubmed
Dingledine,
The glutamate receptor ion channels.
1999,
Pubmed
Dirnagl,
Pathobiology of ischaemic stroke: an integrated view.
1999,
Pubmed
Erreger,
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
2007,
Pubmed
,
Xenbase
Erreger,
Glutamate receptor gating.
2004,
Pubmed
Froemke,
Spike-timing-dependent synaptic plasticity depends on dendritic location.
2005,
Pubmed
Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed
Hansen,
Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements.
2008,
Pubmed
,
Xenbase
Hermit,
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.
2004,
Pubmed
Nacher,
The role of N-methyl-D-asparate receptors in neurogenesis.
2006,
Pubmed
Palmer,
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
2001,
Pubmed
Pérez-Otaño,
Homeostatic plasticity and NMDA receptor trafficking.
2005,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
Waxman,
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
2005,
Pubmed
